GenesisCare - logo
Make an enquiry
Refer a patient

Your state: AU |

down arrow down arrow

Our Centres

down arrow

Our Doctors

down arrow
Make an enquiry
Refer a patient

Our Centres

down arrow

Our Doctors

down arrow

Prostate Cancer

Prostate Cancer
2025-07-08T00:00:00.000+10:00
Ongoing

HRS-5041-103

HRS-5041-103
Genitourinary (GU)

A Phase I, Open-label, Multi-Center, Non-Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Caucasian Subjects with Metastatic Castration-resistant Prostate Cancer

A Phase I, Open-label, Multi-Center, Non-Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Caucasian Subjects with Metastatic Castration-resistant Prostate Cancer

Trial overview

Clinical Area

Medical Oncology

Disease

Prostate

Disease site

Genitourinary (GU)

Study Phase

I

Trial Identifiers

Registration number: NCT06830850

https://clinicaltrials.gov/study/NCT06830850

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

Dr Adrian Lee

BSc (Med) MBBS (Hons) FRACP PhD

Dr Adrian Lee
location pin icon

North Shore

View Profile
Profile Image - Dr Adrian Lee

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.


 

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.